Novell Pharmaceutical Laboratories is primarily engaged in medicinals and botanicals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1982. Novell Pharmaceutical Laboratories was founded by Rudy Soetikno and has grown to become one of Indonesia's leading pharmaceutical companies. The company focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription drugs, over-the-counter medications, and health supplements. Novell operates several manufacturing facilities in Indonesia, ensuring a strong local presence and distribution network. The company has expanded its operations beyond Indonesia, exporting its products to over 30 countries across Asia, Africa, the Middle East, and Latin America. Novell's product portfolio includes a variety of therapeutic categories such as antibiotics, cardiovascular drugs, and pain management medications. Some of its well-known brands include Novell Pain Relief and Novell Cough Syrup. The company has established partnerships with international pharmaceutical firms to enhance its research and development capabilities and to introduce innovative products to the market. Novell is a member of several industry associations, including the Indonesian Pharmaceutical Association, which helps it stay at the forefront of industry trends and regulatory changes. Novell Pharmaceutical Laboratories is committed to improving public health by providing high-quality, affordable medicines. The company's vision is to be a leading pharmaceutical company in the region, recognized for its innovation, quality, and customer satisfaction.
Headquarters
Kota Jakarta Barat Sukabumi Selatan Kebon Jeruk Dki Jakarta
West Jakarta; Jakarta;
Postal Code: 11560
Contact Details: Purchase the PT Novell Pharmaceutical Laboratories report to view the information.
Website: http://www.novellpharm.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service